SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-23-023247
Filing Date
2023-02-17
Accepted
2023-02-17 15:23:10
Documents
3
Group Members
DAVID R. JAMESHAMILTON E. JAMESHAMILTON E. JAMES 2003 CHILDREN'S TRUST

Document Format Files

Seq Description Document Type Size
1 SC 13D tm237208d1_sc13d.htm SC 13D 97155
2 EXHIBIT 99.1 tm237208d1_ex99-1.htm EX-99.1 5649
3 EXHIBIT 99.4 tm237208d1_ex99-4.htm EX-99.4 26868
  Complete submission text file 0001104659-23-023247.txt   131367
Mailing Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE
Business Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE 44 29 2071 0570
Renalytix plc (Subject) CIK: 0001811115 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13D | Act: 34 | File No.: 005-93440 | Film No.: 23642137
SIC: 8071 Services-Medical Laboratories

Mailing Address 499 PARK AVENUE, 27TH FLOOR NEW YORK NY 10022
Business Address 499 PARK AVENUE, 27TH FLOOR NEW YORK NY 10022 212-805-8110
JEFFERSON RIVER CAPITAL LLC (Filed by) CIK: 0001966029 (see all company filings)

IRS No.: 813820238 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D